Weekly Reports | Oct 20 2023
This story features RESMED INC.
For more info SHARE ANALYSIS: RMD
The company is included in ASX50, ASX100, ASX200, ASX300 and ALL-ORDS
For a more comprehensive preview of next week's events, please refer to "The Monday Report", published each Monday morning. For all economic data release dates, ex-div dates and times and other relevant information, please refer to the FNArena Calendar.
By Greg Peel
With yesterday’s September jobs report proving benign despite the fall in the unemployment rate, next Wednesday’s release of September quarter CPI data will be critical to an RBA that appears to have its finger on the trigger.
We will likely see a rise in the headline number due to higher petrol prices, but the core will be key, particularly with regard services inflation and rents.
For the US, the highlight next week, economically, is the first estimate of September quarter GDP on Thursday, followed by September PCE inflation on Friday. The US will also see numbers for new home sales, durable goods orders, and consumer sentiment.
On the corporate front, it’s a big week for quarterly earnings results. Next week features releases from Google, Microsoft, Meta and Amazon, which collectively have to power to either make or break Wall Street.
The ECB meets next week.
New Zealand is closed on Monday.
Tuesday brings flash estimates of global October PMIs.
The local AGM season rolls on next week with too many names to highlight. Quarterly reports also continue to flow.
ResMed ((RMD)) reports September quarter earnings on Friday.
For a calendar of earnings result releases and a summary of earnings results to date, refer to FNArena's Corporate Results Monitor (https://www.fnarena.com/index.php/reporting_season/)
Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" – Warning this story contains unashamedly positive feedback on the service provided.
FNArena is proud about its track record and past achievements: Ten Years On
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: RMD - RESMED INC

